[有时,我也喝水... - - 轻度认知障碍患者的酒精消费]
Carolin Donath1, Elmar Gräßel1, Julia-Sophia Scheuermann1
1Zentrum für Medizinische Versorgungsforschung, Friedrich-Alexander-Universität Erlangen-Nürnberg, Universitätsklinikum Erlangen, Psychiatrische und Psychotherapeutische Klinik, Erlangen.
Psychiatrische Praxis
|September 6, 2023
概括
轻度认知障碍 (MCI) 患者的饮酒习惯与一般人群相似,但患有MCI的女性饮酒风险高于男性. 这凸显了针对性干预措施的必要性,以减少痴呆风险.
科学领域:
- 神经学 神经学
- 公共卫生 公共卫生
- 流行病学 流行病学
背景情况:
- 冒险饮酒是痴呆症的一个已知的风险因素.
- 轻度认知障碍 (MCI) 是正常衰老和痴呆之间的过渡阶段.
- 了解MCI患者的酒精消费模式对于痴呆症预防策略至关重要.
研究的目的:
- 评估被诊断患有轻度认知障碍 (MCI) 的人群中饮酒的患病率和模式.
- 为了确定MCI人群中关于酒精摄入的特定风险群体.
主要方法:
- 在2022年研究了一组270名60岁及以上的MCI患者.
- 收集的数据包括社会人口统计,12个月和30天的酒精消费率,危险消费门 (>10g/20g/天女性/男性) 和狂饮 (≥50g/场合).
- 这项研究是德国随机对照试验 (RCT) "Brainfit-Nutrition"的一部分.
主要成果:
- 大约一半 (50.8%) 患有MCI的参与者报告至少每周喝酒.
- 在MCI队列中,狂饮在17.0%的人群中普遍存在.
- 一个值得注意的发现是,在过去30天内,女性 (34.8%) 与男性 (18.6%) 相比,风险饮酒的患病率更高.
结论:
- 患有MCI的人的整体酒精消费率与65岁及以上的德国普通人口相似.
- 然而,患有MCI的女性患有风险饮酒的患病率明显高.
- 这些发现凸显了针对MCI妇女在饮酒方面采取有针对性的干预措施的必要性,以减轻痴呆风险.
相关概念视频
CNS Depressants: Alcohol and Nicotine
241
Ethanol, a clear colorless alcohol, has been consumed by humans for millennia, but its effects on the body are far from benign. At lower doses, it induces decreased inhibitions and loquaciousness, leading to its social appeal. However, it can cause severe consequences at higher doses, such as coma and respiratory depression, due to its zero-order elimination kinetics. Chronic ethanol abuse wreaks havoc on multiple organ systems, particularly the CNS and the liver. Abrupt cessation of ethanol...
241
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
151
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
151
Alzheimer's Disease: Overview
517
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
517
Cognitive Development During Adulthood
155
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
155
Alzheimer's Disease: Treatment
212
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
212
Dementia
139
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
139


